Skip to content
V$438.91+2.32(+0.53%)Visa Just Raised Its Dividend 16%. Is It a Better Buy Than Mastercard?8:17:32 AM ETCVS$80.90+0.91(+1.14%)RPT-BREAKINGVIEWS-CVS’s problem: investors trust the warning label8:16:38 AM ETCOP$139.45+2.51(+1.83%)STAK Energy Signs Long-Term Agreement to Bring North Slope Natural Gas to Market8:15:00 AM ETMU$759.97-35.49(-4.46%)Is Micron stock a Buy after crashing below $800?8:13:57 AM ETGOOG$289.81+2.51(+0.87%)Meta Paid 1.4 Times What Alphabet Did to Borrow in Euros8:08:00 AM ETCOP$139.45+2.51(+1.83%)ConocoPhillips Profit Rises as Oil Prices Climb8:06:00 AM ETINTC$56.92-1.36(-2.33%)Intel: I Warned Before The 40% Crash, Now I'm Bullish (Rating Upgrade)8:05:00 AM ETASML$1,460.30-35.84(-2.40%)Could $10,000 Invested in ASML Set You Up for Life?8:05:00 AM ETAVGO$317.50-8.20(-2.52%)Broadcom Stock Could Be Approaching a Major Turning Point. Here's the Price Target8:03:07 AM ETVZ$46.70+0.53(+1.15%)Verizon Makes the Holidays Simple with Our Best Deals and Rewards Just for Being a Customer8:01:25 AM ETSHEL$102.84+0.98(+0.96%)Transaction in Own Shares8:00:53 AM ETIBM$256.39+2.07(+0.81%)IBM, AMD, Oak Ridge National Laboratory launch quantum error correction platform8:00:48 AM ETMETA$634.31+4.31(+0.68%)Voters rejected AI data centers over resource concerns. Here's why measuring water usage is hard8:00:01 AM ETISRG$484.18+1.99(+0.41%)World’s First Fully Robotic Transoral Gastric Procedures Completed Using EndoQuest’s Endoluminal Surgical System8:00:00 AM ETGOOG$289.81+2.51(+0.87%)Alphabet: Search Disruption Vs. The Rise Of Carbon8:00:00 AM ETAAPL$354.55+5.04(+1.44%)The new moto buds ultra 27 take audio up a notch with Sound by Bose technology and bring AI live translation to consumers8:00:00 AM ETTM$216.81+17.35(+8.70%)2027 Toyota Tundra: A Bold New Chapter in Full-Size Pickup Excellence with Advanced Towing Tech and the New Trailhunter Package8:00:00 AM ETIBM$256.39+2.07(+0.81%)Oak Ridge National Laboratory, IBM, and AMD Launch New Co-Design Platform for Quantum Error Correction8:00:00 AM ETNVDA$196.95-3.34(-1.67%)Nvidia Stock Is Back at $200. What History Suggests Is the Floor.7:57:00 AM ETAAPL$354.55+5.04(+1.44%)Apple: Demand Is Not The Problem7:54:50 AM ETCOP$139.45+2.51(+1.83%)BRIEF-ConocoPhillips Says Qatar LNG Production Remained Constrained Through Q37:50:36 AM ETMCD$280.65+0.43(+0.15%)McDonald's Is Rallying, but Can You Sleep at Night Owning It?7:48:44 AM ETPLTR$167.30-4.40(-2.56%)Palantir's CEO Just Said What Wall Street Doesn't Want to Hear About AI7:47:36 AM ETMSFT$557.50+1.70(+0.31%)The Same $10,000 in Microsoft and Meta Could Produce Very Different Results by 20307:47:14 AM ET

MMED · NASDAQ

MiniMed Group, Inc.

$19.28 0.00 (0.00%)

Company overview

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

Sector
Healthcare
Industry
Medical - Equipment & Services
Exchange
NASDAQ
Market cap
$5.4B
Employees
8,000
Headquarters
Northridge, CA
CEO
Que Thanh Dallara
Listed
March 5, 2026
P/E
0.00
Dividend yield
0.00%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

10.1013.8217.5421.2624.98
MMED 1D NASDAQ O19.33H19.93L19.11C19.28+0.43 (+2.28%)Vol10.49M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
MMEDMiniMed Group, Inc. Press release MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results PR Newswire
MMEDMiniMed Group, Inc. Stock news BRIEF-Minimed Appoints Dr. David Segal As Chief Medical Officer Reuters
MMEDMiniMed Group, Inc. Press release MiniMed Appoints Dr. David Segal as Chief Medical Officer PR Newswire
MMEDMiniMed Group, Inc. Stock news Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy? The Motley Fool
MMEDMiniMed Group, Inc. Stock news Medtronic Quietly Raised Its Dividend Again. Is It a Buy for Income Investors? 24/7 Wall Street
MMEDMiniMed Group, Inc. Stock news How Many Shares Would It Take to Earn $1,000 a Year From This Future Dividend King? Fool - Investing News
MMEDMiniMed Group, Inc. Stock news MiniMed Announces Board of Directors for its Next Chapter as an Independent Company PRNewsWire
MMEDMiniMed Group, Inc. Press release MiniMed Announces Board of Directors for its Next Chapter as an Independent Company MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the completion of ... PR Newswire
MMEDMiniMed Group, Inc. Press release Medtronic Completes Separation of MiniMed Group, Inc. Medtronic plc (Medtronic; NYSE: MDT) today announced the completion of its separation of MiniMed Group, Inc. (MiniMed; Nasdaq: MMED). "I'm incredibly ... PR Newswire
MMEDMiniMed Group, Inc. Press release MiniMed Completes Separation from Medtronic MiniMed (Nasdaq: MMED) today announced the completion of its separation from Medtronic plc ("Medtronic"; NYSE: MDT), marking its first day as a fully ... PR Newswire
MMEDMiniMed Group, Inc. Stock news Jim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money' Benzinga
MMEDMiniMed Group, Inc. Press release Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer Medtronic plc (Medtronic; NYSE: MDT) today announced the final results of its previously announced offer to exchange shares of common stock of... PR Newswire
MMEDMiniMed Group, Inc. Stock news Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse Benzinga
MMEDMiniMed Group, Inc. Press release Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer Medtronic plc (Medtronic; NYSE: MDT) today announced that, based on preliminary results, its previously announced offer to exchange shares of common... PR Newswire
MMEDMiniMed Group, Inc. Stock news Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There? The Motley Fool
MMEDMiniMed Group, Inc. Stock news Jim Cramer Doesn't Like This Health Care Stock, Sees No Reason To Buy Rambus Benzinga
MMEDMiniMed Group, Inc. Stock news Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc. PRNewsWire
MMEDMiniMed Group, Inc. Press release Responding more frequently to MiniMed Smart MDI alerts linked to better glucose outcomes for people with diabetes PRNewsWire
MMEDMiniMed Group, Inc. Press release MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary PR Newswire
MMEDMiniMed Group, Inc. Stock news Squeeze Watch: 10 Stocks With Over 33% Short Interest Benzinga
FAQ

Questions about MiniMed Group, Inc.

What does MiniMed Group, Inc. do?
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
What is MMED's market cap?
MiniMed Group, Inc. (MMED) is a listed stock with a live quote. The latest market cap on this page is $5.4B.
Where is MiniMed Group, Inc. headquartered?
MiniMed Group, Inc. is headquartered in Northridge, CA.
How do I get MMED news from the API?
Call GET /v1/news?tickers=MMED. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does MMED news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for MMED, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the MMED price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.